Profile data is unavailable for this security.
About the company
Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
- Revenue in JPY (TTM)41.64bn
- Net income in JPY5.06bn
- Incorporated1965
- Employees1.62k
- LocationFuji Pharma Co Ltd5-7, Samban-cho6F, Seito Kaikan,CHIYODA-KU 102-0075JapanJPN
- Phone+81 335563344
- Fax+81 335564455
- Websitehttps://www.fujipharma.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astena Holdings Co Ltd | 52.63bn | 1.62bn | 20.25bn | 1.40k | 12.06 | 0.6838 | 5.26 | 0.3847 | 40.98 | 40.98 | 1,332.61 | 722.46 | 0.8127 | 3.31 | 2.76 | 37,482,540.00 | 2.49 | 2.49 | 4.44 | 4.44 | 32.27 | 25.33 | 3.06 | 2.32 | 0.8713 | -- | 0.3517 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| Fuso Pharmaceutical Industries Ltd | 54.63bn | 1.34bn | 21.13bn | 1.31k | 14.44 | 0.5245 | 6.00 | 0.3869 | 154.89 | 154.89 | 6,295.26 | 4,263.41 | 0.725 | 3.31 | 2.20 | 41,572,300.00 | 1.78 | 1.79 | 2.95 | 2.87 | 25.29 | 27.78 | 2.45 | 2.59 | 1.09 | 65.13 | 0.2835 | 45.95 | 2.79 | 2.14 | 8.23 | 10.60 | -1.72 | -2.64 |
| Medical Data Vision Co Ltd | 6.42bn | 979.13m | 23.38bn | 262.00 | 22.79 | 5.25 | 22.13 | 3.64 | 25.63 | 25.63 | 168.05 | 111.30 | 1.15 | 140.01 | 6.11 | 24,500,100.00 | 17.17 | 16.16 | 24.01 | 20.88 | 78.38 | 81.90 | 14.87 | 15.52 | 2.58 | 24.66 | 0.00 | 19.98 | 5.15 | 12.40 | 12.48 | 69.75 | -23.95 | -- |
| Pharma Foods International Co., Ltd. | 65.08bn | 4.76bn | 24.51bn | 670.00 | 5.10 | 2.57 | 4.57 | 0.3767 | 165.17 | 165.17 | 2,257.80 | 327.80 | 1.84 | 2.22 | 12.71 | 97,135,820.00 | 13.44 | 8.40 | 48.12 | 19.20 | 79.89 | 81.34 | 7.32 | 3.85 | 0.8449 | 91.33 | 0.6839 | 28.26 | 13.94 | 53.90 | 923.80 | 57.92 | 51.63 | -- |
| Cuorips Inc | 39.89m | -598.68m | 27.37bn | 46.00 | -- | 4.48 | -- | 686.18 | -76.49 | -76.49 | 5.13 | 766.30 | 0.0081 | 3.93 | 39.73 | 867,130.40 | -12.10 | -- | -12.39 | -- | 45.79 | -- | -1,500.91 | -- | 35.89 | -- | 0.00 | -- | 175.12 | -- | -20.45 | -- | -- | -- |
| SanBio Co Ltd | 0.00 | -2.64bn | 28.48bn | 29.00 | -- | 10.10 | -- | -- | -40.50 | -40.50 | 0.00 | 41.11 | 0.00 | -- | -- | 0.00 | -43.74 | -42.00 | -52.38 | -48.88 | -- | -- | -- | -4,790.72 | -- | -- | 0.1923 | -- | -- | -- | 52.44 | -- | 53.94 | -- |
| StemRIM Inc | 2.35bn | 179.40m | 28.66bn | 44.00 | 136.13 | 2.92 | -- | 12.20 | -0.1097 | -0.1097 | 37.43 | 159.71 | 0.2453 | -- | -- | 53,409,090.00 | 1.87 | -6.71 | 1.89 | -6.83 | -- | -- | 7.63 | -45.80 | 78.90 | 652.72 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
| Mizuho Medy Co Ltd | 10.99bn | 3.77bn | 31.72bn | 180.00 | 8.40 | 2.02 | 7.99 | 2.89 | 396.27 | 396.27 | 1,153.85 | 1,645.86 | 0.5776 | 2.04 | 2.04 | 61,054,080.00 | 19.84 | 31.46 | 23.70 | 39.78 | 73.47 | 74.85 | 34.34 | 33.64 | 6.45 | -- | 0.00 | 34.83 | -37.49 | 11.34 | -51.85 | 32.64 | -17.74 | 32.85 |
| Koa Shoji Holdings Co Ltd | 22.27bn | 2.86bn | 33.48bn | 297.00 | 11.72 | 1.52 | 9.40 | 1.50 | 72.09 | 72.09 | 562.08 | 554.93 | 0.7777 | 5.99 | 2.42 | 74,979,020.00 | 9.97 | 7.91 | 12.38 | 9.93 | 30.12 | 28.74 | 12.83 | 10.48 | 3.69 | 29.24 | 0.1197 | 19.64 | 8.35 | 8.27 | 13.90 | 29.60 | -21.26 | 15.52 |
| Fuji Pharma Co Ltd | 41.64bn | 5.06bn | 39.36bn | 1.62k | 7.64 | 0.9208 | 4.79 | 0.9452 | 208.19 | 208.19 | 1,713.27 | 1,726.70 | 0.5039 | 1.40 | 2.82 | 25,687,230.00 | 6.12 | 4.10 | 8.90 | 5.58 | 38.51 | 42.41 | 12.15 | 7.55 | 0.7165 | -- | 0.3947 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Daito Pharmaceutical Co Ltd | 45.19bn | 3.28bn | 39.64bn | 1.01k | 12.15 | 0.7624 | 5.83 | 0.8771 | 207.85 | 207.85 | 2,864.81 | 3,311.81 | 0.6193 | 1.81 | 2.65 | 44,701,280.00 | 4.35 | 6.99 | 5.64 | 9.29 | 21.38 | 22.71 | 7.03 | 8.83 | 1.15 | -- | 0.1231 | 17.08 | 3.77 | 2.49 | -22.88 | 3.43 | 7.48 | 12.70 |
| Seikagaku Corp | 34.68bn | 1.31bn | 42.27bn | 976.00 | 31.00 | 0.566 | 14.61 | 1.22 | 24.00 | 24.00 | 635.69 | 1,314.47 | 0.4431 | 1.75 | 4.31 | 35,530,740.00 | 1.67 | 0.438 | 1.80 | 0.4797 | 50.52 | 55.91 | 3.77 | 1.07 | 5.44 | -- | 0.0055 | 452.20 | -4.00 | 2.09 | -40.10 | -10.63 | 8.40 | 0.00 |
Data as of May 01 2024. Currency figures normalised to Fuji Pharma Co Ltd's reporting currency: Japanese Yen JPY
9.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 526.12k | 2.13% |
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 448.40k | 1.81% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 327.02k | 1.32% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 261.30k | 1.06% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 211.50k | 0.85% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 206.70k | 0.84% |
| Mellon Investments Corp.as of 04 Apr 2024 | 89.90k | 0.36% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024 | 87.50k | 0.35% |
| Samarang LLPas of 30 Jun 2022 | 55.70k | 0.23% |
| Mayr Investment Managers GmbHas of 31 Jan 2024 | 43.90k | 0.18% |
More ▼
Data from 30 Jun 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
